211 related articles for article (PubMed ID: 35383860)
1. [Corrigendum] SPAG9 expression is increased in human prostate cancer and promotes cell motility, invasion and angiogenesis
Chen F; Lu Z; Deng J; Han X; Bai J; Liu Q; Xi Y; Zheng J
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35383860
[TBL] [Abstract][Full Text] [Related]
2. [Corrigendum] Long non‑coding RNA AC245100.4 promotes prostate cancer tumorigenesis via the microRNA‑145‑5p/RBBP5 axis.
Xie H; Zhao J; Wan J; Zhao J; Wang Q; Yang X; Yang W; Lin P; Yu X
Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36799194
[TBL] [Abstract][Full Text] [Related]
3. [Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression.
Cai C; He H; Duan X; Wu W; Mai Z; Zhang T; Fan J; Deng T; Zhong W; Liu Y; Zhong W; Zeng G
Oncol Rep; 2023 Apr; 49(4):. PubMed ID: 36825583
[TBL] [Abstract][Full Text] [Related]
4. [Corrigendum] Overexpression of HES6 has prognostic value and promotes metastasis via the Wnt/β-catenin signaling pathway in colorectal cancer.
Xu Y; Liu X; Zhang H; Zhu Z; Wu X; Wu X; Li S; Song L; Xu X
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35322866
[TBL] [Abstract][Full Text] [Related]
5. [Corrigendum] Hsp90 inhibitor 17‑AAG inhibits stem cell‑like properties and chemoresistance in osteosarcoma cells via the Hedgehog signaling pathway.
Shu X; Liu H; Zhen R; Jie Y; Chen L; Qi H; Wang C; Wang R; Chen D; Ran Y
Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37350398
[TBL] [Abstract][Full Text] [Related]
6. [Corrigendum] CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
Ji J; Shen I; Li Y; Liu Y; Shang Z; Niu Y
Oncol Rep; 2023 Sep; 50(3):. PubMed ID: 37477123
[TBL] [Abstract][Full Text] [Related]
7. [Corrigendum] Nogo‑B promotes the epithelial‑mesenchymal transition in HeLa cervical cancer cells via Fibulin‑5.
Xiao W; Zhou S; Xu H; Li H; He G; Liu Y; Qi Y
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35348187
[TBL] [Abstract][Full Text] [Related]
8. [Corrigendum] DJ‑1 promotes cell proliferation and tumor metastasis in esophageal squamous cell carcinoma via the Wnt/β‑catenin signaling pathway.
Jin F; Wang H; Li D; Fang C; Li W; Shi Q; Diao Y; Ding Z; Dai X; Tao L; Sunagawa M; Wu F; Qian Y; Liu Y
Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35147201
[TBL] [Abstract][Full Text] [Related]
9. [Corrigendum] RON and c‑Met facilitate metastasis through the ERK signaling pathway in prostate cancer cells.
Yin B; Liu Z; Wang Y; Wang X; Liu W; Yu P; Duan X; Liu C; Chen Y; Zhang Y; Pan X; Yao H; Liao Z; Tao Z
Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36004460
[TBL] [Abstract][Full Text] [Related]
10. [Corrigendum] Ski prevents TGF‑β‑induced EMT and cell invasion by repressing SMAD‑dependent signaling in non‑small cell lung cancer.
Yang H; Zhan L; Yang T; Wang L; Li C; Zhao J; Lei Z; Li X; Zhang HT
Oncol Rep; 2021 Feb; 45(2):787-788. PubMed ID: 33416110
[TBL] [Abstract][Full Text] [Related]
11. [Corrigendum) RNA interference‑mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin‑induced apoptosis dependent on JNK activation.
He M; Sun HG; Hao JY; Li YL; Yu JK; Yan YY; Zhao L; Li N; Wang Y; Bai XF; Yu ZJ; Zheng ZH; Mi XY; Wang EH; Wei MJ
Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35543152
[TBL] [Abstract][Full Text] [Related]
12. [Corrigendum] Induction of microRNA‑let‑7a inhibits lung adeno-carcinoma cell growth by regulating cyclin D1.
Zhao W; Hu JX; Hao RM; Zhang Q; Guo JQ; Li YJ; Xie N; Liu LY; Wang PY; Zhang C; Xie SY
Oncol Rep; 2024 May; 51(5):. PubMed ID: 38456515
[TBL] [Abstract][Full Text] [Related]
13. [Corrigendum] miR‑490‑5p regulates the proliferation, migration, invasion and epithelial‑mesenchymal transition of pharyngolaryngeal cancer cells by targeting mitogen‑activated protein kinase kinase kinase 9.
Abdeyrim A; Cheng X; Lian M; Tan Y
Int J Mol Med; 2022 Jun; 49(6):. PubMed ID: 35383861
[TBL] [Abstract][Full Text] [Related]
14. [Corrigendum] MicroRNA‑10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer.
Xiao H; Li H; Yu G; Xiao W; Hu J; Tang K; Zeng J; He W; Zeng G; Ye Z; Xu H
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35642686
[TBL] [Abstract][Full Text] [Related]
15. [Corrigendum] Thymoquinone inhibits epithelial‑mesenchymal transition in prostate cancer cells by negatively regulating the TGF‑β/Smad2/3 signaling pathway.
Kou B; Liu W; Zhao W; Duan P; Yang Y; Yi Q; Guo F; Li J; Zhou J; Kou Q
Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36734273
[TBL] [Abstract][Full Text] [Related]
16. [Corrigendum] MicroRNA-375 inhibits glioma cell proliferation and migration by downregulating RWDD3 in vitro.
Ji CX; Fan YH; Xu F; Lv SG; Ye MH; Wu MJ; Zh XG; Wu L
Oncol Rep; 2020 Nov; 44(5):2317-2318. PubMed ID: 33000270
[TBL] [Abstract][Full Text] [Related]
17. [Corrigendum] microRNA‑181a‑5p functions as an oncogene in renal cell carcinoma.
Lai Y; Zhao L; Hu J; Quan J; Chen P; Xu J; Guan X; Lai Y; Ni L
Mol Med Rep; 2024 Apr; 29(4):. PubMed ID: 38362959
[TBL] [Abstract][Full Text] [Related]
18. [Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
Sun X; Xin S; Zhang Y; Jin L; Liu X; Zhang J; Mei W; Zhang B; Ma W; Ye L
Int J Oncol; 2024 Jan; 64(1):. PubMed ID: 38038145
[TBL] [Abstract][Full Text] [Related]
19. [Corrigendum] BCL‑3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1.
Tu K; Liu Z; Yao B; Xue Y; Xu M; Dou C; Yin G; Wang J
Oncol Rep; 2023 Jan; 49(1):. PubMed ID: 36484414
[TBL] [Abstract][Full Text] [Related]
20. [Corrigendum] Resveratrol inhibits the invasion and metastasis of colon cancer through reversal of epithelial‑mesenchymal transition via the AKT/GSK‑3β/Snail signaling pathway.
Yuan L; Zhou M; Huang D; Wasan HS; Zhang K; Sun L; Huang H; Ma S; Shen M; Ruan S
Mol Med Rep; 2022 Dec; 26(6):. PubMed ID: 36222306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
